01Patients and carers
Experienced value and access
Comprehensibility, accessibility, burden, trust and continuity influence whether a solution is accepted and sustained.
Need understandable value and a safe care pathway.
Entry into German outpatient care
German outpatient healthcare is not one single market.
A viable market entry connects the care situation, access, financing, provider economics, decision paths and implementation. Market size alone answers none of these questions.
Care settingGerman outpatient market
Operating perspectiveFive practice sites
Professional experiencePharma and business development
FocusFrom market thesis to routine
Six market layers
An addressable market emerges only when six layers align.
Every layer can limit an attractive market thesis or reveal which condition still needs to be created before entry.
- 01Care problem
Is the market defined precisely enough?
Specify the patient group, care situation, current alternative and intended improvement rather than counting a broad indication or institution type.
Which relevant problem becomes better for whom? - 02Access
May and can the solution enter the care pathway?
Assess regulatory, professional, contractual, technical and organizational requirements as separate access questions.
Which condition must be met before the first responsible use? - 03Financing
Who pays for what and carries which risk?
Consider reimbursement, budgets, contracts, investment, ongoing cost and possible shifts in effort together.
Is there a financeable route or only theoretical value? - 04Provider economics
Does the model work for a practice or MVZ?
Model time, people, rooms, capacity, materials, documentation, revenue effect and operating risk from the provider perspective.
Does a viable operating model remain after additional effort? - 05Decision system
Who decides, uses, pays and influences?
Purchase, prescription, application, financing, IT approval and routine use may sit with different actors.
Which approval enables a start — and which enables routine use? - 06Adoption and learning
Can implementation become reliable routine?
Define workflow, trust, training, data, feedback, pilot criteria and requirements for scale before starting.
Which evidence justifies the next step?
A distributed decision system
Market entry rarely has one single customer.
Benefit, decision, budget, accountability and daily work often sit with different actors. A robust strategy separates these roles and then reconnects them.
02Physicians and care teams
Professional accountability and routine
Evidence, suitability, safety, time, training, documentation and exceptions shape responsible use.
Need professional clarity and a workable workflow.03Practice and MVZ management
Investment and operating model
Capacity, workforce, IT, procurement, liquidity, revenue, risk and strategic fit form one connected decision.
Need economic viability and clear accountability.04Access and system partners
Framework, contracts and scale
Payers, contracting partners, procurement, regulation and other system actors shape the conditions under which use becomes possible.
Need robust evidence, clear accountability and compliant routes.
Market-entry sequence
Do not begin with the channel. Begin with addressable care delivery.
A good plan connects the market thesis with implementation. Findings from provider reality or a pilot can change earlier assumptions and need to feed back into strategy.
- 01Focused market
Specify the market thesis
Define the care problem, target group, current alternative, value hypothesis and exclusion criteria.
- 02Addressability map
Map the market architecture
Structure access, financing, actors, decision paths, regional or sector differences and dependencies.
- 03Viable use thesis
Test provider reality
Examine patient pathway, workflow, capacity, cost, revenue, accountability, IT and exceptions concretely.
- 04Go-to-market design
Design the entry route
Connect target segment, partners, pilot, proposition, evidence, support and success criteria.
- 05Evidence-based scale
Learn and scale
Evaluate effect, effort, side effects and transferability; adapt strategy and operating model before expansion.
Three product logics
The same market layers, different critical questions.
Medicines, medical technology and digital solutions meet different professional accountability, workflows and investment logics. A generic market strategy is therefore insufficient.
Between evidence, prescription and care pathway
Professional selection, access, procurement, reimbursement, switching, communication and follow-up belong in one use pathway.
How does product availability become responsible care delivery?Between investment, capacity and consequence
Assess the device, consumables, rooms, qualification, time, utilization, maintenance, documentation and downstream decision together.
Which additional decision or service justifies the operating effort?Between functionality, integration and accountability
Data access, interfaces, workflow change, exceptions, review, privacy, security and human approval determine real usability.
Which process measurably improves, and who remains accountable?
Provider economics
Value does not automatically arise where effort occurs.
A market-entry strategy needs to show who receives value, who invests, who carries additional work and how operations remain viable over time.
Care-delivery effect
Which patient, professional or organizational improvement should emerge, and how will it be recognized?
Additional effort
Which time, skills, rooms, systems, materials and coordination are needed for implementation and routine?
Payment and investment route
Who finances acquisition, implementation, routine use and potential transition losses?
Operating model
Which capacity, revenue effect, risk allocation and management routine keep use stable?
Typical false shortcuts
Four shortcuts make a market look larger than it is addressable.
These patterns confuse theoretical potential with concrete use and shift unresolved conditions into sales or a pilot.
Market size equals addressable market.
A large patient population says nothing yet about access, financing, decision-making or organizational usability.
The buyer is the customer.
Purchase, clinical accountability, budget, daily application and experienced value may sit with different people.
Reimbursement creates adoption.
A financed route does not resolve capacity, workflow, trust, training or accountability.
A successful pilot already proves scale.
A supported special case proves transferability only when resources, exceptions and conditions are transparent.
Potential work products
From market thesis to a testable entry decision.
Work products are tailored to the specific decision and do not replace binding legal, regulatory or reimbursement advice.
Market and care-delivery architecture
Structure target segment, care pathway, access, financing, actors and dependencies in one market map.
Decision value: market boundaries and prioritiesStakeholder and decision map
Assign decision, influence, use, budget, effort, accountability and communication needs to the relevant actors.
Decision value: a realistic access routeProvider-economics and workflow model
Test value, resources, workflow change, capacity, investment, revenue effect and risk from the provider perspective.
Decision value: a viable use thesisGo-to-market and implementation roadmap
Translate target segment, partners, evidence, pilot, support model, measures and scaling criteria into a sequence.
Decision value: justified next steps
Connected perspectives
Market entry does not end with initial access.
Depending on the open question, the care system, economics, product adoption or sector depth provide the next step.
Outpatient care
Understand access, patient pathways, capacity, financing, data and accountability as one connected system.
View the system perspectiveHealth economics
Make benefit, resources, incentives, financing and the distribution of effort transparent enough for trade-offs.
View the economic perspectiveProduct adoption
Assess how market access becomes responsible and workable routine use in care delivery.
View the adoption logicOphthalmology
Make market, product and implementation questions concrete in the deepest sector focus.
View ophthalmologyFree decision check
Download the decision check
Is the market-entry question ready for robust assessment?
The PDF helps structure the decision question, care-delivery reality, economic assumptions, evidence and implementation risks before a conversation.
Clear boundary
Market and care-delivery analysis, not binding market-access approval.
The content structures market, care-delivery, organizational and economic questions. It does not replace individual clinical, legal, regulatory, tax, data-protection or binding reimbursement advice. Clinical decisions and formal approvals remain with the accountable professionals. Patient data, trade secrets and confidential documents do not belong in an initial enquiry.
Test a market-entry question through the care-delivery perspective
Briefly describe the product, target segment, intended decision and largest open point. This helps identify which market, provider or implementation question should be resolved first.